Company / Operating Cash Flow per Share
PROCEPT BioRobotics Corp Operating Cash Flow per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.88
FY2025
5-year range
-$3.48 / -$0.88
FY2021-FY2025
Trend
+53.7%
vs FY2024
Sector context
#144 of 156
Health Care
What the data says
Among 156 Health Care companies, PROCEPT BioRobotics Corp is in the bottom 8% for operating cash flow per share. Improved from $-2.29 to $-0.88 over the past 2 years.
Based on SEC 10-K filings.
-0.88 in FY2025.
Improved from $-2.29 to $-0.88 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 156This company -$0.88 Sector average -$9.11
▼
+90.3% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 53.7% year-over-year.
- Ranks #144 out of 156 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.88 | +53.7% |
| FY2024 | -$1.90 | +16.7% |
| FY2023 | -$2.29 | -26.2% |
| FY2022 | -$1.81 | +48.0% |
| FY2021 | -$3.48 | +73.6% |
| FY2020 | -$13.20 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026